Search results for "46"

showing 10 items of 1176 documents

Towards a framework for treatment effectiveness in schizophrenia

2014

Georg Juckel,1 Andrea de Bartolomeis,2 Philip Gorwood,3 Sergey Mosolov,4 Luca Pani,5 Alessandro Rossi,6 Julio Sanjuan7 1Department of Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Bochum, Germany; 2Laboratory of Molecular Psychiatry and Unit of Treatment Resistant Psychosis, University School of Medicine of Naples Federico II, Napoli, Italy; 3Groupe Hospitalier Sainte-Anne (CMME), Paris-Descartes University, Paris, France; 4Moscow Research Institute of Psychiatry, Moscow, Russia; 5Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy; 6Università de L’Aquila, L’Aquila, Italy; 7Clinic Hospital, Spanish Mental Hea…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentAlternative medicineSatisfactionNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAntipsychoticAssessment scaleExtrapyramidal symptomsmedicineFunctioningCognitive skillAntipsychoticPsychiatryRC346-429Biological PsychiatryDisease burdenOriginal Researchassessment scalesbusiness.industryMental illneMental illnessmedicine.diseasemental illnessAntipsychotic; Assessment scales; Functioning; Mental illness; SatisfactionPsychiatry and Mental HealthMental illnessSchizophreniaNeurology. Diseases of the nervous systemmedicine.symptombusinessAssessment scalesRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: Efficacy following prior methylphenidate trea…

2016

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT), in which ATX was included as a reference arm, and in the open-label phase of a randomized-withdrawal study (RWS). Participants were 6–17 years old with ADHD Rating Scale version IV (ADHD-RS-IV) scores ≥32 and Clinical Global Impressions – Severity scores ≥4. RCT participants received dose-optimized GXR (1–7 mg/day), ATX (10–100 mg/day), or placebo for 10–13 weeks. RWS participants received dose-o…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmenteffectivenessmethylphenidateNeurosciences. Biological psychiatry. NeuropsychiatryPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawInternal medicinemental disordersmedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesPsychiatryRC346-429child and adolescentguanfacineOriginal Researchbusiness.industryMethylphenidate05 social sciencesAtomoxetinetrialmedicine.disease030227 psychiatryGuanfacineinadequate respondersStimulantNeurology. Diseases of the nervous systembusinessGXRatomoxetine050104 developmental & child psychologymedicine.drugRC321-571
researchProduct

Prevalence of eating disorders and eating attacks in narcolepsy

2008

Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter TonnPsychiatry Department, University of Mainz, GermanyAbstract: Narcoleptic patients suffer frequently from obesity and type II diabetes. Most patients show a deficit in the energy balance regulating orexinergic system. Nevertheless, it is not known, why narcoleptic patients tend to be obese. We examined 116 narcoleptic patients and 80 controls with the structured interview for anorectic and bulimic eating disorders (SIAB) to test the hypothesis that typical or atypical eating attacks or eating disorders may be more frequent in narcoleptic patients. No difference in the current prevalence of eating disorders bulimia nervosa, b…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentnarcolepsyNeurosciences. Biological psychiatry. NeuropsychiatryAnorexiaAnorexia nervosaeating attackBinge-eating disordermental disordersMedicinePsychiatryRC346-429Biological PsychiatryOriginal Researchbusiness.industryBulimia nervosadigestive oral and skin physiologymedicine.diseaseObesityPsychiatry and Mental healthEating disordersbulimiaanorexiaeating disorderAnorecticSIABNeurology. Diseases of the nervous systemmedicine.symptombusinessNarcolepsyRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia

2013

Giuseppe Battaglia,1,3 Marianna Alesi,2 Michele Inguglia,4 Michele Roccella,2 Giovanni Caramazza,3 Marianna Bellafiore,1,3 Antonio Palma1,3 1Department of Law, Social and Sport Science, University of Palermo, Palermo, Italy; 2Department of Psychology, University of Palermo, Palermo Italy; 3Regional Sports School of CONI Sicilia, Sicily, Italy; 4Local Health of Palermo, Palermo, Italy Abstract: Physical activity is an important aspect of good health for everyone; it is even more important for psychiatric patients who usually live an unhealthy lifestyle. In recent years, there has been growing focus on the use of soccer as a vehicle to improve the health of subjects with severe mental illness…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentpsychotic subjectsmedicine.medical_treatmentNeurosciences. Biological psychiatry. NeuropsychiatrySettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneMedicineRC346-429schizophrenia mental illness psychotic subjects sport exercise soccerAntipsychoticBiological PsychiatryOriginal ResearchSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportiveexercisebusiness.industryAnthropometryMental illnessmedicine.diseasemental illnesssoccerSettore MED/39 - Neuropsichiatria InfantileschizophreniaPsychiatry and Mental healthAdd on treatmentSprintPhysical therapyNeurology. Diseases of the nervous systemmedicine.symptomsportbusinesshuman activitiesBody mass indexWeight gainRC321-571Diagnosis of schizophreniaNeuropsychiatric Disease and Treatment
researchProduct

Neuropsychology and anorexia nervosa. Cognitive and radiological findings

2012

Introduction: Research into neuropsychological impairments present in the patients suffering from anorexia nervosa (AN) has advanced considerably, in the past decades. It now provides neuropsychologists with a wide field of knowledge of the changes found in the cerebral and cognitive capabilities of these patients, as well as their reversible or static features, thereby yielding a characteristic profile of neuropsychological impairment in AN. Development: We present a review updated to December 2010 of the results delivered by studies of both morphological and cognitive changes, providing us with an updated theoretical and practical framework for conducting future research. Conclusions: The…

medicine.medical_specialtyNeuropsychologyPosterior parietal cortexCognitionDiseaseWide fieldlcsh:RC346-429Anorexia nervosa (differential diagnoses)Radiological weaponCognitive ChangesmedicinePsychologyPsychiatrylcsh:Neurology. Diseases of the nervous systemNeurología (English Edition)
researchProduct

Gait Disorders Questionnaire–Promising Tool for Virtual Reality Designing in Patients With Parkinson's Disease

2019

Background: Gait disorders (GD) are frequent and disabling symptoms in patients with Parkinson's disease, mostly because they significantly limit mobility and often lead to fear of falls or actual falls. Nowadays, rehabilitation is considered to be the most effective nonpharmacological approach to reduce risk of falls. Using paradigms in virtual reality (VR) is a promising tool in neurorehabilitation because of the potential improvement in motor learning and improvement in daily functioning by replicating everyday real-life scenarios. Objective: To identify the most prevalent everyday situations which impair gait in PD that could be simulated in virtual reality (VR) environment. Methods: A …

medicine.medical_specialtyParkinson's diseaseParkinson's diseasemedicine.medical_treatmentMokken scaleDiseaseVirtual realitygaitlcsh:RC346-429freezing of gait03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicine030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemNeurorehabilitationOriginal ResearchneurorehabilitationRehabilitationbusiness.industrymedicine.diseaseGaitNeurologyvirtual realityNeurology (clinical)Motor learningbusiness030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.

2016

Background. Rosai-Dorfmann disease (RDD) is a rare, idiopathic non-Langerhans cell histiocytosis, affecting children and young adults, that commonly presents as painless, massive cervical lymphadenopathy with fever, weight loss, and polyclonal hypergammaglobulinemia. Cervical lymphadenopathy and extranodal involvement are the main presentations. On the contrary, ophthalmic involvement and localisation in the central nervous system are rare.Case Report. An old man was admitted to our hospital for first seizure. Brain imaging studies revealed on the left an extra-axial thickening of the dura mater with enhancement and perilesional oedema, infiltrating the sphenoorbital fissure and an isointen…

medicine.medical_specialtyPathologyDura materRosai-Dorfmann disease mercaptopurine treatmentCase Reportlcsh:RC346-42903 medical and health sciences0302 clinical medicineCervical lymphadenopathymedicineExtranodal Involvementlcsh:Neurology. Diseases of the nervous systemRosai–Dorfman diseasebusiness.industrymedicine.diseaseDebulkingMercaptopurineHistiocytosismedicine.anatomical_structure030220 oncology & carcinogenesisOptic nerveRadiologymedicine.symptomGeneral Agricultural and Biological Sciencesbusiness030217 neurology & neurosurgerymedicine.drug
researchProduct

Reduced Risk of Reoperations With Modern Deep Brain Stimulator Systems: Big Data Analysis From a United States Claims Database

2021

Objective: There have been significant improvements in the design and manufacturing of deep brain stimulation (DBS) systems, but no study has considered the impact of modern systems on complications. We sought to compare the relative occurrence of reoperations after de novo implantation of modern and traditional DBS systems in patients with Parkinson's disease (PD) or essential tremor (ET) in the United States.Design: Retrospective, contemporaneous cohort study.Setting: Multicenter data from the United States Centers for Medicare and Medicaid Services administrative claims database between 2016 and 2018.Participants: This population-based sample consisted of 5,998 patients implanted with a …

medicine.medical_specialtyPediatricsDeep brain stimulationcomplicationsmedicine.medical_treatmentParkinson's diseasePopulationMedicarebehavioral disciplines and activitiesmedicineneurosurgeryeducationProspective cohort studyessential tremorRC346-429Original Researcheducation.field_of_studyEssential tremorbusiness.industrymedicine.diseasedeep brain stimulationbig data & analyticsnervous systemNeurologyNeurology (clinical)NeurosurgeryNeurology. Diseases of the nervous systemComplicationbusinessMedicaidCohort studysurgical riskFrontiers in Neurology
researchProduct

Health-Related Quality of Life Is Severely Affected in Primary Orthostatic Tremor

2018

International audience; Background: Primary orthostatic tremor (POT) is a movement disorder characterized by unsteadiness upon standing still due to a tremor affecting the legs. It is a gradually progressive condition with limited treatment options. Impairments in health-related quality of life (HQoL) seem to far exceed the physical disability associated with the condition.Methods: A multi-center, mixed-methodology study was undertaken to investigate 40 consecutive patients presenting with POT to four movement disorder centers in France. HQoL was investigated using eight quantitative scales and a qualitative study which employed semi-structured interviews. Qualitative data were analyzed wit…

medicine.medical_specialtyPhysical disabilityQualitative propertyprogressiveFear of fallinglcsh:RC346-429Grounded theory03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Physical medicine and rehabilitationMedicine030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemOriginal Researchbusiness.industryMultimethodology3. Good healthprimary orthostatic tremorhealth-related quality of lifeNeurology[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC][SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]movement disorderNeurology (clinical)Thematic analysismedicine.symptombusinessmixed-method methodology030217 neurology & neurosurgeryNeuroscienceQualitative research
researchProduct

Association Between Fatigue and Cognitive Impairment at 6 Months in Patients With Ischemic Stroke Treated With Acute Revascularization Therapy.

2019

Background: Fatigue is a frequent symptom after stroke. We aimed to determine the association between fatigue and cognitive performance in patients with ischemic stroke who received acute revascularization therapy (IV thrombolysis and/or mechanical thrombectomy).Methods: Seventy patients were prospectively included in the stroke unit of the University Hospital of Dijon, France. A follow-up was performed at 6 months with clinical examination, fatigue assessment by the Fatigue Severity Scale (FSS), and a comprehensive neuropsychological evaluation. Patients with fatigue (FSS score >4) were compared with patients without fatigue. Neuropsychological factors associated with fatigue at 6 month…

medicine.medical_specialtyPhysical examinationlcsh:RC346-42903 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineischemic strokeMedicineMemory impairment030212 general & internal medicineCognitive rehabilitation therapyEffects of sleep deprivation on cognitive performanceStrokelcsh:Neurology. Diseases of the nervous systemDepression (differential diagnoses)Original Researchcognitive impairmentmedicine.diagnostic_testbusiness.industrymedicine.diseasestrokeNeurologydepressionoutcomefatigueNeurology (clinical)business030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in neurology
researchProduct